PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

One size doesn't fit all when it comes to products for preventing HIV from anal sex

2021-03-06
(Press-News.org) The initial insights from the study, aptly named DESIRE (Developing and Evaluating Short-acting Innovations for Rectal Use), are being reported on March 6 in a Science Spotlight session at the virtual meeting of the Conference on Retroviruses and Opportunistic Infections (CROI), March 6-10. The presentation will be available for registered participants and media to view throughout the meeting.

Conducted by the National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), DESIRE focused on potential delivery methods for rectal microbicides - topical products being developed and tested to reduce a person's risk of acquiring HIV and other sexually transmitted infections from anal sex. MTN researchers are particularly interested in on-demand options - used around the time of sex - and behaviorally congruent options that deliver anti-HIV drugs via products people may already be using as part of their sex routine.

"DESIRE stands out as a unique study because we took a step back and said, 'Let's figure out the modality without automatically pairing it with a drug'," explained José A. Bauermeister, Ph.D., M.P.H., study protocol chair and Albert M. Greenfield Professor of Human Relations at the University of Pennsylvania. "It gave us the ability to manipulate the delivery method without having to worry about how reactions to a particular drug might confound the results. We also had people trying out these methods in their own lives, and only then asked them to weigh the attributes of each." As such, he said, participants weren't making choices based on theoretical concepts, but instead using real experiences to guide their preferences.

Launched in 2019, DESIRE, also referred to as MTN-035, is the first study to explore multiple placebo methods for delivering a rectal microbicide. The three delivery methods assessed included a fast-dissolving placebo insert approximately two-thirds of an inch in length, a placebo suppository approximately an inch and a half in length, and a commercially available 120 mL douche bottle that participants were instructed to fill with clean tap or bottled water prior to use.

The study enrolled 217 participants who used each rectal delivery method for a month at a time, with a week-long break in between. Study participants, whose average age was 25 years, included cisgender men who have sex with men (79 percent) as well as transgender women (19 percent) and transgender men (2 percent) who have sex with men. The participants, based in Malawi, Peru, South Africa, Thailand and the United States (Birmingham, Pittsburgh and San Francisco), were instructed to use each method between 30 minutes and 3 hours prior to engaging in receptive anal sex, or once a week if they had not engaged in receptive anal sex in a given week.

To evaluate the acceptability of each method, participants were asked to complete a four-item survey once a week by text, commonly referred to as short message service (SMS), in their preferred language. After a month of using a particular delivery method, they were asked to complete a computer-assisted interview, with a subset of participants also completing an in-depth interview led by one of the study researchers.

At their final study visit, participants ranked attributes of a hypothetical product for preventing HIV from anal sex, and researchers used conjoint analysis - a market research approach that measures the value consumers place on features of a product or service - to calculate the percentage of weight participants gave to each attribute. They found that efficacy was the strongest determinant of participants' stated modality choice at 30 percent, followed by delivery method (18 percent) and side effects (17 percent). Other factors - timing of use before sex, duration of protection, frequency of use, and the need for a prescription - were not weighted as having as much importance by study participants. Through further analysis, researchers identified the participants' most preferred package based on the product features: A douche used 30 minutes before sex with 95 percent efficacy that offers three to five days of protection. This ideal product would also only need to be used once a week, have no side effects, and be available over the counter.

While this market research approach offered insights into the most common package of features, participants also underscored how each of the modalities could offer unique advantages in their daily lives.

"As you might expect, the context of the participants' lives informed their product choice," said Dr. Bauermeister. "When asked to rank the most preferred product attributes, they based their answers on their own experiences and the tradeoffs they might make in real-life situations." In some instances, he explained, discretion might be important, so a small tablet in the form of a fast-dissolving rectal insert that could be carried in your pocket might be the best option. At other times, hygiene may be a priority and a douche would be preferred. As a pre-lubricated product, even the suppository had unexpected advantages with some participants commenting about it's potential as an alternative to sexual lubricant.

"The lesson we learned from MTN-035 is that even though the douche was preferred overall, we shouldn't assume it's right for everyone every time they plan to have sex," said Dr. Bauermeister. "Depending on who you are, what you do and where you live, it may not be a viable, or even a desirable, option for HIV prevention. At the end of the day, people could see all three of these modalities fitting into their lives."

Researchers like Dr. Bauermeister are hopeful these results will inform the development of rectal microbicides moving forward, and lead to expanded choices in preventing HIV from anal sex.

INFORMATION:

MTN-035 was conducted at the following clinical research sites (CRSs): the College of Medicine-Johns Hopkins Research Project in Blantyre, Malawi; the IMPACTA CRS in Lima, Peru; the Wits Reproductive Health and HIV Institute in Johannesburg, South Africa; the Chiang Mai University HIV Prevention CRS in Thailand; and, in the United States, the University of Pittsburgh CRS, Bridge HIV CRS in San Francisco, and University of Alabama at Birmingham CRS.

The MTN is funded by the National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all part of the NIH. The placebo rectal insert used in the study was developed by CONRAD, a not-for-profit research and development organization based at Eastern Virginia Medical School in Norfolk, Va.

Dr. Bauermeister's presentation "Developing and Evaluating Short-Acting Innovations for Rectal Use (Desire): Acceptability and choice for three placebo products used with receptive anal intercourse among young MSM and TG people" will be viewable beginning at 12:01 a.m. (EST), Saturday, March 6. Please visit http://www.croiconference.org for more information.

The MTN is funded by the U.S. National Institutes of Health grants UM1AI068633, UM1AI068615, UM1AI106707. CONRAD's support for MTN-035 and provision of the placebo insert is made possible by the generous support of the American people through a Cooperative Agreement (AID-OAA-A-14-00010) with the U.S. Agency for International Development/U.S. President's Emergency Plan for AIDS Relief.

About the Microbicide Trials Network The Microbicide Trials Network (MTN) is an HIV/AIDS clinical trials network established in 2006 by the National Institute of Allergy and Infectious Diseases with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health. Based at Magee-Womens Research Institute and the University of Pittsburgh, the MTN brings together international investigators and community and industry partners whose work is focused on the rigorous evaluation of promising microbicides - products applied inside the vagina or rectum that are intended to prevent the sexual transmission of HIV - from the earliest phases of clinical study to large-scale trials that support potential licensure of these products for widespread use. More information about the MTN is available at https://mtnstopshiv.org.



ELSE PRESS RELEASES FROM THIS DATE:

"Magic sand" might help us understand the physics of granular matter

2021-03-06
Tokyo, Japan - Researchers from Tokyo Metropolitan University have studied the properties of mixtures of silicone-coated "magic sand", a popular kid's toy, and normal sand. Silicone-coated sand particles were found to interact with each other only, and not with other sand particles. The team discovered that adding silicone-coated sand beyond a certain threshold leads to an abrupt change in clustering and rigidity, a simple, useful way to potentially tune the flow of granular materials for industry. Sand is a fascinating material. It can flow and be poured like a liquid, ...

WRAIR, Duke scientists find evidence of monoclonal antibodies activity against malaria

2021-03-05
Scientists at Walter Reed Army Institute of Research, in a collaboration with Duke University, have confirmed that monoclonal antibodies can be an effective tool in the global fight against malaria. The study, led by Dr. Sheetij Dutta, chief of the Structural Vaccinology Laboratory at WRAIR, showed that mAbs such as CIS43 were most effective in a culture-based assay that measured malaria parasites' ability to infect a human liver cell, while another mAb 317 showed the best activity in a mouse infection model. Dutta added "difference in assay outcomes for mAbs could reflect distinct sites on the circumsporozoite protein that can be exploited for developing improved vaccines." The ...

Physics camp has proven benefits for high school girls

Physics camp has proven benefits for high school girls
2021-03-05
HOUSTON - (March 5, 2021) - Even a small effort up front can boost the abilities and confidence of girls as they anticipate taking challenging science courses. A long-running summer program at Rice University and elsewhere that trains high school girls in basic physics concepts has proven successful in helping them thrive when they take on full courses the next year. When leaders of Rice's two-week day camp looked at similar programs beyond Houston, they found participants scored 3% better in high school physics than their counterparts who did not have the equivalent summer experience. "That doesn't seem like a lot, but it's really hard to move the needle on student outcomes, so 3% is significant," said Carolyn Nichol, an assistant ...

With unfair police treatment, the tragedy is not limited to the incident itself

2021-03-05
BUFFALO, N.Y. - New research using a nationally representative sample of more than 12,000 participants shows the collateral consequences victims are likely to confront following unfair treatment by police. Michael Brown, George Floyd and Tamir Rice are just some of those who have died recently at the hands of police. Their names are now tragically familiar, but thousands of other people who are unjustly stopped, searched or questioned by law enforcement will likely experience a range of detrimental outcomes associated with unfair police treatment, including depression, suicidal thoughts, drug use, and a loss of self-efficacy, according to Christopher ...

Building networks not enough to expand rural broadband

2021-03-05
ITHACA, N.Y. - Public grants to build rural broadband networks may not be sufficient to close the digital divide, new Cornell University research finds. High operations and maintenance costs and low population density in some rural areas result in prohibitively high service fees - even for a subscriber-owned cooperative structured to prioritize member needs over profits, the analysis found. Decades ago, cooperatives were key to the expansion of electric and telephone service to underserved rural areas, spurred by New Deal legislation providing low-interest government grants and loans. Public funding for rural ...

Rapid 3D printing method moves toward 3D-printed organs

2021-03-05
BUFFALO, N.Y. -- It looks like science fiction: A machine dips into a shallow vat of translucent yellow goo and pulls out what becomes a life-sized hand. But the seven-second video, which is sped-up from 19 minutes, is real. The hand, which would take six hours to create using conventional 3D printing methods, demonstrates what University at Buffalo engineers say is progress toward 3D-printed human tissue and organs -- biotechnology that could eventually save countless lives lost due to the shortage of donor organs. "The technology we've developed is 10-50 times faster than the industry standard, and it works with large ...

Online dating: Super effective, or just... superficial?

Online dating: Super effective, or just... superficial?
2021-03-05
According to the Pew Research Center, 1 in 10 American adults have landed a long-term relationship from an online dating app, such as Tinder, OKCupid and Match.com. But what compels people to "swipe right" on certain profiles and reject others? New research from William Chopik, an associate professor in the Michigan State University Department of Psychology, and Dr. David Johnson from the University of Maryland, finds that people's reason for swiping right is based primarily on attractiveness and the race of a potential partner, and that decisions are often made in less than a second. "Despite online dating becoming an increasingly popular way for people to meet one another, ...

New 'split-drive' system puts scientists in the (gene) driver seat

New split-drive system puts scientists in the (gene) driver seat
2021-03-05
Powerful new genetic engineering methods have given scientists the potential to revolutionize several sectors of global urgency. So-called gene drives, which leverage CRISPR technology to influence genetic inheritance, carry the promise of rapidly spreading specific genetic traits throughout populations of a given species. Gene-drive technologies applied in insects, for example, are being designed to halt the spread of devastating diseases such as malaria and dengue by preventing mosquito hosts from becoming infected. In agricultural fields, gene-drives are being developed to help control or eliminate economically ...

Survey identifies factors in reducing clinical research coordinator turnover

Survey identifies factors in reducing clinical research coordinator turnover
2021-03-05
Strong, collaborative relationships with principal investigators are a key factor of longevity in clinical research coordinator positions -- an essential, but increasingly transient job in executing treatment-advancing clinical trials, Vanderbilt University Medical Center researchers found. Danielle Buchanan, BS, clinical translational research coordinator III in the Department of Neurology, and Daniel Claassen, MD, MS, chief of the Division of Cognitive Disorders and associate professor of Neurology, found the top factor for retention is a close working relationship between clinical research coordinators (CRCs) and the study's principal investigator that emphasizes respect and collaboration. Salary followed as the next factor for retention among 85 former or current CRCs who responded to ...

Study reveals how egg cells get so big

Study reveals how egg cells get so big
2021-03-05
Egg cells are by far the largest cells produced by most organisms. In humans, they are several times larger than a typical body cell and about 10,000 times larger than sperm cells. There's a reason why egg cells, or oocytes, are so big: They need to accumulate enough nutrients to support a growing embryo after fertilization, plus mitochondria to power all of that growth. However, biologists don't yet understand the full picture of how egg cells become so large. A new study in fruit flies, by a team of MIT biologists and mathematicians, reveals that the process through which the oocyte ...

LAST 30 PRESS RELEASES:

Algorithms could help improve judicial decisions

Scientists uncover a multibillion-year epic written into the chemistry of life

Monitoring diseases through sweat becomes accessible to everyone

Mathematical model driven evolutionary therapy dosing exploiting cancer cell plasticity

Biodiversity in the margins: Merging farmlands affects natural pest control

1 in 8 pregnant people have a disability, but significant gaps exist in the provision of accessible care

Statins associated with decreased risk for CVD and death, even in very old adults

Climate change is moving tree populations away from the soil fungi that sustain them

Secrets of sargassum: Scientists advance knowledge of seaweed causing chaos in the Caribbean and West Africa

Bioinformatics approach could help optimize soldiers’ training for improved readiness and recovery

Earth scientists describe a new kind of volcanic eruption

Warmer wetter climate predicted to bring societal and ecological impact to the Tibetan Plateau

Feeding infants peanut products protects against allergy into adolescence

Who will like beetle skewers? What Europeans think about alternative protein food

ETRI wins ‘iF Design Award’ for mobile collaborative robot

Combating carbon footprint: novel reactor system converts carbon dioxide into usable fuel

Investigating the origin of circatidal rhythms in freshwater snails

Altering cellular interactions around amyloid plaques may offer novel Alzheimer’s treatment strategies

Brain damage reveals part of the brain necessary for helping others

Surprising properties of elastic turbulence discovered

Study assesses cancer-related care at US hospitals predominantly serving minority populations compared with non-minority serving hospitals

First in-human investigator-initiated clinical trial to launch for refractory prostate cancer patients: Novel alpha therapy targets prostate-specific membrane antigen

Will generative AI change the way universities communicate?

Artificial Intelligence could help cure loneliness, says expert

Echidnapus identified from an ‘Age of Monotremes’

Semaglutide may protect kidney function in individuals with overweight or obesity and cardiovascular disease

New technique detects novel biomarkers for kidney diseases with nephrotic syndrome

Political elites take advantage of anti-partisan protests to disrupt politics

Tiny target discovered on RNA to short-circuit inflammation, UC Santa Cruz researchers find

Charge your laptop in a minute? Supercapacitors can help; new research offers clues

[Press-News.org] One size doesn't fit all when it comes to products for preventing HIV from anal sex